ASMQ Launch

[ April 2008 ]
Rio de Janeiro, Brazil

Farmanguinhos/Fiocruz and DNDi launched ASMQ, the new fixed-dose combination of artesunate (AS) and mefloquine (MQ), now registered in Brazil. Developed and delivered by a worldwide collaboration of public partners, ASMQ will soon be available throughout Latin American and Southeast Asia.

PRESENTATIONS

First Session – Status of Implementation and R&D of Artemisinin-based Combination Therapies (ACTs) (Bernard Pécoul/Drugs for Neglected Diseases initiative – DNDi, Switzerland)

Rationale for ACTs [311KB]

(Piero Olliaro/ Special Programme for Research and Training in Tropical Diseases – TDR, Switzerland) [English]

Status of R&D Portfolio for New Malaria Treatments [477KB]
(J. Carl Craft/Medicines for Malaria Venture – MMV, Switzerland) [English]

Status of ACTs Implementation in Latin America [3.7MB]
(Roberto Montoya/Pan American Health Organization – PAHO, Brazil) [Portuguese/Spanish]

Status of ACTs Implementation in Brazil [414KB]
(José Lázaro de Brito Ladislau/National Program of Malaria Control/ Ministry of Health – PNCM/ MoH, Brazil) [Portuguese]

Second Session – Development of ASMQ combination (Carlos Morel/Fiocruz, Brazil)

FACT: An Innovative Partnership [703KB]
(Jean-René Kiechel/ DNDi, Switzerland) [English]

ASMQ Product Profile: From Blue Print to Blue Pill [2.1MB]
(Jorge Mendonça, Alessandra Viçosa, Luciana Gonçalves and Érico Daemon/ Farmanguinhos – Fiocruz, Brazil) [Portuguese/English]

Pharmacokinetics in Healthy Normal Volunteers and Patients [148KB]
(Michel Vaillant /CRP Santé Luxembourg) [English]

Phase III and Field Studies [1.1MB]
(François Nosten/Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Elizabeth Ashley [English]

Third Session – Clinical Studies (Piero Olliaro/TDR, Switzerland)

Status of Clinical Studies in Thailand [884KB]
(François Nosten/ Shoklo Malaria Research Unit, Thailand) – Presentation prepared by Dr. Julien Zwang [English]

Status of Clinical Studies in Peru [1.15MB]
(Cristiam Angeles/ Loreto Regional Health Directorate, Peru) [Spanish]

Status of Clinical Studies in Brazil: State of Acre [7.4MB]
(Marize Lucena, Health Surveillance Secretariat – State of Acre; Ana Carolina Santelli/PNCM – MoH, Brazil) [Portuguese]

Status of Clinical Studies in Tanzania: African Perspective [116KB]
(Andrew Kitua/National Institute for Medical Research – NIMR, Tanzania) [English]

Other Planned Clinical Studies, including India and Myanmar
(Isabela Ribeiro/ DNDi, Brazil) [English]